COVID-19: With fewer side-effects, Ivermectin still used widely in India despite WHO recommendation against it
The Hindu
‘WHO recommends against use of Ivermectin for COVID-19 except within clinical trials,’ Soumya Swaminathan, WHO’s chief scientist, tweeted earlier this week.
Still listed in India as a under home isolation Ivermectin, according to the World Health Organisation’s recent direction, is not recommended for general use. This orally-administered drug is included in for people with mild infection even though its maker has now clarified that there is no evidence of its efficacy against the viral disease. “Safety and efficacy are important when using any drug for a new indication. WHO recommends against use of ‘Ivermectin’ for COVID-19 except within clinical trials,” Soumya Swaminathan, WHO’s chief scientist, tweeted earlier this week.More Related News

The draft policy for “Responsible Digital Use Among Students”, released on Monday by the Department of Health and Family Welfare, has recommended that parents set structured routines with clear screen-time rules and prioritise privacy, safety, and open conversation with children on digital well-being.












